CS logo
small CS logo
KPPK GmbH, Studienzentrum

Koblenz, Germany
Studying center in Koblenz, Rhineland-Palatinate
Emil-Schüller-Straße 29, 56068 Koblenz

About KPPK GmbH, Studienzentrum


"Wir führen klinische Studien zur Diagnostik und Therapie von chronischen Erkrankungen der Atemwege durch. Insbesondere erproben wir Medikamente für die Therapie von Asthma bronchiale, COPD (chronische Bronchitis / Emphysem), Bronchiektasie, allergischen Erkrankungen der Atemwege. Unser Team aus Prüfärzten und hoch qualifizierten Studienassistentinnen arbeitet stets prinzipientreu für das gemeinsame Ziel – Verbesserte Therapiemöglichkeiten, die für unsere Patienten und nachfolgende Generationen von Nutzen sind."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at KPPK GmbH, Studienzentrum


During the past decade, KPPK GmbH, Studienzentrum conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "KPPK GmbH, Studienzentrum" #1 collaborator was "Boehringer Ingelheim" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

Clinical Trials Conditions at KPPK GmbH, Studienzentrum


According to Clinical.Site data, the most researched conditions in "KPPK GmbH, Studienzentrum" are "Asthma" (1 trials) and "Pulmonary Disease, Chronic Obstructive" (1 trials). Many other conditions were trialed in "KPPK GmbH, Studienzentrum" in a lesser frequency.

Clinical Trials Intervention Types at KPPK GmbH, Studienzentrum


Most popular intervention types in "KPPK GmbH, Studienzentrum" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Respimat" (1 trials), "placebo" (1 trials) and "risankizumab" (1 trials). Other intervention names were less common.

Clinical Trials Genders at KPPK GmbH, Studienzentrum


The vast majority of trials in "KPPK GmbH, Studienzentrum" are 2 trials for "All" genders.

Clinical Trials Status at KPPK GmbH, Studienzentrum


Currently, there are NaN active trials in "KPPK GmbH, Studienzentrum". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in KPPK GmbH, Studienzentrum, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in KPPK GmbH, Studienzentrum, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".